Carman Research

Smyrna, Georgia 30080

0 studies enrolling now · 39 studies all time

What they study most

ADHD, Acute Migraine, Adult Attention Deficit Hyperactivity Disorder, Alzheimer´s Disease, Anxiety Disorders, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorders, Attention-Deficit/Hyperactivity Disorder, Binge Eating Disorder, Bipolar Depression, Bipolar Disorder

Studies at this site

• A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania — Completed
• Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder — Completed
• A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder — Completed
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder — Completed
• Genomics Used to Improve DEpression Decisions — Completed
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease — Stopped early
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) — Completed
• Dasotraline Adult ADHD Study — Completed
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) — Completed
• Open-label Safety Study in Adults With ADHD — Completed
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy — Completed
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder — Completed
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Stopped early
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder — Completed
• Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression — Completed
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder — Completed
• Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. — Completed
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• A Study of Aripiprazole in Patients With Major Depressive Disorder — Completed
• Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Switching to Iloperidone From Other Antipsychotics in Schizophrenia — Completed
• Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder — Stopped early
• An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) — Completed
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression — Completed
• Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) — Completed
• Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression — Completed